• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于文献回顾和网络药理学评价柚皮素治疗 COPD 的潜在治疗选择。

Evaluation of Naringenin as a Promising Treatment Option for COPD Based on Literature Review and Network Pharmacology.

机构信息

Guangdong Engineering and Technology Research Center for Quality and Efficacy Re-Evaluation of Post-Marketed TCM, State Key Laboratory of Biocontrol and Guangdong Provincial Key Laboratory of Plant Resources, School of Life Sciences, Sun Yat-sen University, Guangzhou 510275, China.

出版信息

Biomolecules. 2020 Dec 8;10(12):1644. doi: 10.3390/biom10121644.

DOI:10.3390/biom10121644
PMID:33302350
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7762561/
Abstract

Chronic obstructive pulmonary disease (COPD) is a chronic respiratory disease characterized by incompletely reversible airflow limitation and seriously threatens the health of humans due to its high morbidity and mortality. Naringenin, as a natural flavanone, has shown various potential pharmacological activities against multiple pathological stages of COPD, but available studies are scattered and unsystematic. Thus, we combined literature review with network pharmacology analysis to evaluate the potential therapeutic effects of naringenin on COPD and predict its underlying mechanisms, expecting to provide a promising tactic for clinical treatment of COPD.

摘要

慢性阻塞性肺疾病(COPD)是一种慢性呼吸系统疾病,其特征是气流受限不完全可逆,由于其高发病率和死亡率,严重威胁着人类的健康。柚皮素作为一种天然的类黄酮,已经显示出对 COPD 的多个病理阶段具有多种潜在的药理活性,但现有研究较为分散且不系统。因此,我们将文献综述与网络药理学分析相结合,评估柚皮素对 COPD 的潜在治疗作用,并预测其潜在机制,期望为 COPD 的临床治疗提供一个有前景的策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a56/7762561/83a7c1747ce6/biomolecules-10-01644-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a56/7762561/e1b559715e26/biomolecules-10-01644-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a56/7762561/9655e232836a/biomolecules-10-01644-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a56/7762561/1b4c6bc1be35/biomolecules-10-01644-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a56/7762561/a4f74913f13e/biomolecules-10-01644-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a56/7762561/3350f45bd874/biomolecules-10-01644-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a56/7762561/360a7d92666a/biomolecules-10-01644-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a56/7762561/83a7c1747ce6/biomolecules-10-01644-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a56/7762561/e1b559715e26/biomolecules-10-01644-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a56/7762561/9655e232836a/biomolecules-10-01644-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a56/7762561/1b4c6bc1be35/biomolecules-10-01644-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a56/7762561/a4f74913f13e/biomolecules-10-01644-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a56/7762561/3350f45bd874/biomolecules-10-01644-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a56/7762561/360a7d92666a/biomolecules-10-01644-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a56/7762561/83a7c1747ce6/biomolecules-10-01644-g007.jpg

相似文献

1
Evaluation of Naringenin as a Promising Treatment Option for COPD Based on Literature Review and Network Pharmacology.基于文献回顾和网络药理学评价柚皮素治疗 COPD 的潜在治疗选择。
Biomolecules. 2020 Dec 8;10(12):1644. doi: 10.3390/biom10121644.
2
Emerging pharmaceutical therapies for COPD.慢性阻塞性肺疾病的新兴药物疗法
Int J Chron Obstruct Pulmon Dis. 2017 Jul 21;12:2141-2156. doi: 10.2147/COPD.S121416. eCollection 2017.
3
Future treatment strategies for COPD.慢性阻塞性肺疾病的未来治疗策略。
Clin Cornerstone. 2003;5(1):45-51. doi: 10.1016/s1098-3597(03)90008-1.
4
Management of an acute exacerbation of copd: are we ignoring the evidence?慢性阻塞性肺疾病急性加重的管理:我们是否忽视了相关证据?
Thorax. 2002 Oct;57 Suppl 2(Suppl 2):II15-II23.
5
Targeted Treatments for Chronic Obstructive Pulmonary Disease (COPD) Using Low-Molecular-Weight Drugs (LMWDs).使用低分子量药物(LMWD)治疗慢性阻塞性肺疾病(COPD)的靶向治疗。
J Med Chem. 2019 Jul 11;62(13):5944-5978. doi: 10.1021/acs.jmedchem.8b01520. Epub 2019 Feb 12.
6
3,4,5-Trihydroxycinnamic acid exerts a protective effect on pulmonary inflammation in an experimental animal model of COPD.3,4,5-三羟基肉桂酸对 COPD 实验动物模型中的肺部炎症具有保护作用。
Int Immunopharmacol. 2020 Aug;85:106656. doi: 10.1016/j.intimp.2020.106656. Epub 2020 Jun 5.
7
New anti-inflammatory targets for chronic obstructive pulmonary disease.慢性阻塞性肺疾病的新抗炎靶点。
Nat Rev Drug Discov. 2013 Jul;12(7):543-59. doi: 10.1038/nrd4025.
8
Targeting oxidant-dependent mechanisms for the treatment of respiratory diseases and their comorbidities.针对氧化应激相关机制治疗呼吸疾病及其合并症。
Curr Opin Pharmacol. 2018 Jun;40:1-8. doi: 10.1016/j.coph.2017.11.013. Epub 2017 Dec 6.
9
Oxidation pathway and exacerbations in COPD: the role of NAC.慢性阻塞性肺疾病中的氧化途径与病情加重:N-乙酰半胱氨酸的作用
Expert Rev Respir Med. 2016;10(1):89-97. doi: 10.1586/17476348.2016.1121105. Epub 2015 Dec 15.
10
[Pharmacological treatment of COPD and future of anti-inflammatory therapy].[慢性阻塞性肺疾病的药物治疗与抗炎治疗的未来]
Med Klin (Munich). 2006 Apr 15;101(4):283-92. doi: 10.1007/s00063-006-1036-6.

引用本文的文献

1
Metabolic engineering approaches for the biosynthesis of antibiotics.用于抗生素生物合成的代谢工程方法。
Microb Cell Fact. 2025 Jan 31;24(1):35. doi: 10.1186/s12934-024-02628-2.
2
Network Pharmacology and Experimental Validation of Jinwei Decoction for Enhancement of Glucocorticoid Anti-Inflammatory Effect in COPD through miR-155-5p.基于miR-155-5p探讨金苇汤增强糖皮质激素在慢性阻塞性肺疾病中抗炎作用的网络药理学及实验验证
Comb Chem High Throughput Screen. 2025;28(2):351-370. doi: 10.2174/0113862073279344240215050056.
3
Intratracheal Administration of Stem Cell Membrane-Cloaked Naringin-Loaded Biomimetic Nanoparticles Promotes Resolution of Acute Lung Injury.

本文引用的文献

1
Clinical characteristics of Japanese patients with chronic obstructive pulmonary disease (COPD) with comorbid interstitial lung abnormalities: A cross-sectional study.慢性阻塞性肺疾病(COPD)合并间质性肺异常的日本患者的临床特征:一项横断面研究。
PLoS One. 2020 Nov 10;15(11):e0239764. doi: 10.1371/journal.pone.0239764. eCollection 2020.
2
Progress in the mechanism and targeted drug therapy for COPD.COPD 的发病机制及靶向药物治疗的研究进展。
Signal Transduct Target Ther. 2020 Oct 27;5(1):248. doi: 10.1038/s41392-020-00345-x.
3
The Potential Role and Regulatory Mechanisms of MUC5AC in Chronic Obstructive Pulmonary Disease.
气管内给予干细胞膜包裹的载柚皮苷仿生纳米颗粒可促进急性肺损伤的消退。
Antioxidants (Basel). 2024 Feb 26;13(3):282. doi: 10.3390/antiox13030282.
4
Anti-inflammatory reprogramming of microglia cells by metabolic modulators to counteract neurodegeneration; a new role for Ranolazine.代谢调节剂对小胶质细胞的抗炎重编程以对抗神经退行性变;雷诺嗪的新作用。
Sci Rep. 2023 Nov 17;13(1):20138. doi: 10.1038/s41598-023-47540-8.
5
Age-related hearing loss and its potential drug candidates: a systematic review.年龄相关性听力损失及其潜在的候选药物:一项系统综述。
Chin Med. 2023 Sep 20;18(1):121. doi: 10.1186/s13020-023-00825-6.
6
Effect of Structural Differences in Naringenin, Prenylated Naringenin, and Their Derivatives on the Anti-Influenza Virus Activity and Cellular Uptake of Their Flavanones.柚皮素、异戊烯基化柚皮素及其衍生物的结构差异对其黄酮类化合物抗流感病毒活性和细胞摄取的影响。
Pharmaceuticals (Basel). 2022 Nov 28;15(12):1480. doi: 10.3390/ph15121480.
7
Characterization of somatic mutations and pathway alterations during hepatocellular carcinoma vascular invasion using next-generation sequencing.使用二代测序技术对肝细胞癌血管侵犯过程中的体细胞突变和信号通路改变进行特征分析。
J Gastrointest Oncol. 2022 Aug;13(4):1864-1874. doi: 10.21037/jgo-22-556.
8
Naringenin suppresses BEAS-2B-derived extracellular vesicular cargoes disorder caused by cigarette smoke extract thereby inhibiting M1 macrophage polarization.柚皮苷抑制香烟提取物引起的 BEAS-2B 衍生细胞外囊泡货物紊乱,从而抑制 M1 巨噬细胞极化。
Front Immunol. 2022 Jul 18;13:930476. doi: 10.3389/fimmu.2022.930476. eCollection 2022.
9
Identification of Potential Key Genes in the Pathogenesis of Chronic Obstructive Pulmonary Disease Through Bioinformatics Analysis.通过生物信息学分析鉴定慢性阻塞性肺疾病发病机制中的潜在关键基因
Front Genet. 2021 Nov 3;12:754569. doi: 10.3389/fgene.2021.754569. eCollection 2021.
10
Pharmacologic Activities of Plant-Derived Natural Products on Respiratory Diseases and Inflammations.植物源天然产物对呼吸系统疾病和炎症的药理活性。
Biomed Res Int. 2021 Oct 4;2021:1636816. doi: 10.1155/2021/1636816. eCollection 2021.
黏蛋白 5AC 在慢性阻塞性肺疾病中的潜在作用及调控机制。
Molecules. 2020 Sep 27;25(19):4437. doi: 10.3390/molecules25194437.
4
Naringenin loaded multifunctional nanoparticles to enhance the chemotherapeutic efficacy in hepatic fibrosis.柚皮素载多功能纳米粒增强肝纤维化的化疗疗效。
Biomed Microdevices. 2020 Sep 21;22(4):68. doi: 10.1007/s10544-020-00524-1.
5
The roles of endothelin and its receptors in cigarette smoke-associated pulmonary hypertension with chronic lung disease.内皮素及其受体在与慢性肺部疾病相关的香烟烟雾相关性肺动脉高压中的作用。
Pathol Res Pract. 2020 Sep;216(9):153083. doi: 10.1016/j.prp.2020.153083. Epub 2020 Jun 23.
6
Defective insulin receptor signaling in patients with gestational diabetes is related to dysregulated miR-140 which can be improved by naringenin.妊娠糖尿病患者胰岛素受体信号转导缺陷与 miR-140 失调有关,柚皮素可改善这种失调。
Int J Biochem Cell Biol. 2020 Nov;128:105824. doi: 10.1016/j.biocel.2020.105824. Epub 2020 Aug 16.
7
The PI3K/AKT/mTOR pathway regulates autophagy to induce apoptosis of alveolar epithelial cells in chronic obstructive pulmonary disease caused by PM2.5 particulate matter.PI3K/AKT/mTOR信号通路通过调节自噬来诱导由PM2.5颗粒物引起的慢性阻塞性肺疾病中肺泡上皮细胞的凋亡。
J Int Med Res. 2020 Jul;48(7):300060520927919. doi: 10.1177/0300060520927919.
8
Association Between Serum S100A8/S100A9 Heterodimer and Pulmonary Function in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.血清 S100A8/S100A9 异二聚体与慢性阻塞性肺疾病急性加重期患者肺功能的关系。
Lung. 2020 Aug;198(4):645-652. doi: 10.1007/s00408-020-00376-9. Epub 2020 Jul 13.
9
Th1/Th17 Cytokine Profiles are Associated with Disease Severity and Exacerbation Frequency in COPD Patients.Th1/Th17细胞因子谱与慢性阻塞性肺疾病患者的疾病严重程度和急性加重频率相关。
Int J Chron Obstruct Pulmon Dis. 2020 Jun 8;15:1287-1299. doi: 10.2147/COPD.S252097. eCollection 2020.
10
MicroRNAs in chronic airway diseases: Clinical correlation and translational applications.慢性气道疾病中的 microRNAs:临床相关性与转化应用。
Pharmacol Res. 2020 Oct;160:105045. doi: 10.1016/j.phrs.2020.105045. Epub 2020 Jun 23.